109 related articles for article (PubMed ID: 32880619)
1. Characteristics of lipid metabolism-related gene expression-based molecular subtype in papillary thyroid cancer.
Xu M; Sun T; Wen S; Zhang T; Wang X; Cao Y; Wang Y; Sun X; Ji Q; Shi R; Qu N
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1166-1170. PubMed ID: 32880619
[No Abstract] [Full Text] [Related]
2. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract][Full Text] [Related]
4. The prognostic potential of alpha-1 type I collagen expression in papillary thyroid cancer.
Huang C; Yang X; Han L; Fan Z; Liu B; Zhang C; Lu T
Biochem Biophys Res Commun; 2019 Jul; 515(1):125-132. PubMed ID: 31128912
[TBL] [Abstract][Full Text] [Related]
5. Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16.
Spirina LV; Chizhevskaya SY; Kondakova IV; Choinzonov EL
Bull Exp Biol Med; 2018 Dec; 166(2):237-240. PubMed ID: 30488195
[TBL] [Abstract][Full Text] [Related]
6. IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
Karagiannis AK; Philippou A; Tseleni-Balafouta S; Zevolis E; Nakouti T; Tsopanomichalou-Gklotsou M; Psarras V; Koutsilieris M
Anticancer Res; 2019 Jun; 39(6):2811-2819. PubMed ID: 31177118
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
[TBL] [Abstract][Full Text] [Related]
10. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Properties of the Antisense lncRNA
Esposito R; Esposito D; Pallante P; Fusco A; Ciccodicola A; Costa V
Cancer Res; 2019 May; 79(9):2124-2135. PubMed ID: 30862713
[No Abstract] [Full Text] [Related]
12. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
[TBL] [Abstract][Full Text] [Related]
13. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.
Ding C; Yu H; Shi C; Shi T; Qin H; Cui Y
Biomed Pharmacother; 2019 Feb; 110():528-536. PubMed ID: 30530288
[TBL] [Abstract][Full Text] [Related]
14. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
15. Mts1 Up-regulation is Associated With Aggressive Pathological Features in Thyroid Cancer.
Cheon MG; Son YW; Lee JH; Jang HH; Chung YS
Cancer Genomics Proteomics; 2019; 16(5):369-376. PubMed ID: 31467231
[TBL] [Abstract][Full Text] [Related]
16.
Wen J; Lin B; Lin L; Chen Y; Wang O
Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
[TBL] [Abstract][Full Text] [Related]
17. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2.
Qiu K; Xie Q; Jiang S; Lin T
J Clin Lab Anal; 2020 Feb; 34(2):e23044. PubMed ID: 31670857
[TBL] [Abstract][Full Text] [Related]
18. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance.
Kim HS; Choi JH; Lee JY; Kang J; Myung JK; Kim WH; Jang BG
Sci Rep; 2020 Mar; 10(1):4853. PubMed ID: 32184420
[TBL] [Abstract][Full Text] [Related]
20. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
